22 March 2012
GSK to Invest £500m in New UK Biopharmaceutical Facility
The investment will create up to 1,000 jobs, boost the UK life-sciences sector, and enhance production at sites in Scotland. The new facility in Ulverston will focus on biopharmaceutical manufacturing.